Table 3.
Treatment Groups | CyA (ng/ml) |
---|---|
Control (n=2) | NA |
Vehicle (n=4) | NA |
CyA (n=7) | 336, 6010, 2095, 2040, 2455, 2680, 2320 |
CyA + Apo (n=6) | 1038, 1780, 1605, 1370, 1715, 1580 |
CyA + anti IL-6 (n=4) | 412, 795, 945, 319 |
Treatment Groups | CyA (ng/ml) |
---|---|
Control (n=2) | NA |
Vehicle (n=4) | NA |
CyA (n=7) | 336, 6010, 2095, 2040, 2455, 2680, 2320 |
CyA + Apo (n=6) | 1038, 1780, 1605, 1370, 1715, 1580 |
CyA + anti IL-6 (n=4) | 412, 795, 945, 319 |